| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |